An increase in ARX gene dosage results in a range of disorders, including developmental and epileptic encephalopathy, intellectual developmental disorder, lissencephaly, Partington syndrome, Proud syndrome, and hydranencephaly with abnormal genitalia, such as cryptorchidism and hypospadias. This evidence concerns the gene ARX and corpus callosum agenesis-abnormal genitalia syndrome.